文献速递MDS 与骨髓增殖性肿瘤

非del(5q)骨髓增生异常综合征相关基因位点的全基因组关联荟萃分析

Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis.
PubMed 文献 · Blood Adv · 2019-01-01

该研究对两组欧洲血统非del(5q) MDS病例与对照进行全基因组关联荟萃分析,识别出8个接近全基因组显著性的MDS相关位点,其中5个位点所在或邻近基因在MDS骨髓细胞中表达上调,并涉及先天免疫调控。PLA2G4A高表达与EYA2低表达与较差总生存相关,EYA2表达为独立有利预后因素。

要点

  • 非del(5q) MDS中识别出8个接近全基因组显著性的易感位点。
  • 5个位点所在或邻近基因在MDS骨髓细胞中表达显著上调。
  • PLA2G4A高表达与NRAS、RUNX1、ASXL1、EZH2突变相关。

核心结论

  • 在8个提示性MDS相关位点中,5个映射到MDS中上调的基因,这些基因在先天免疫中具有功能作用,可能与MDS有生物学相关性。

研究设计与样本

  • 研究对两组样本集进行全基因组关联研究:555例MDS病例对比2964例对照,以及352例MDS病例对比2640例对照,均为欧洲基因组 ancestry 的非del(5q) MDS病例,并进行了荟萃分析。

主要发现

  • 荟萃分析识别出8个接近全基因组显著性的MDS相关位点:1q31.1(PLA2G4A)、3p14.1(FAM19A4)、5q21.3(EFNA5)、6p21.33、10q23.1(GRID1)、12q24.32、15q26.1和20q13.12(EYA2)。
  • 映射在基因内或附近的5个位点,其基因表达在MDS骨髓细胞中较对照显著上调(P < .01)。
  • PLA2G4A表达较高与较差总生存相关(P = .039),EYA2表达较低与较差总生存相关(P = .037)。
  • PLA2G4A高表达与NRAS突变(P < .001)、RUNX1突变(P = .012)、ASXL1突变(P = .007)和EZH2突变(P = .038)相关。
  • EYA2表达是独立于年龄、性别和修订版国际预后评分系统的有利风险因素(相对风险0.67;P = .048)。

关键数值与推荐

  • PLA2G4A高表达与较差总生存相关(P = .039),EYA2低表达与较差总生存相关(P = .037)。
  • EYA2表达的相对风险为0.67(P = .048),为独立有利预后因素。

临床怎么用

  • 这些基因在先天免疫中具有调控作用,先天免疫是MDS发病的关键驱动因素。
  • EYA2过表达诱导先天免疫激活,而抑制EYA2可恢复原代MDS细胞的集落形成能力,提示造血恢复和可能的临床相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myelodysplastic syndromes (MDS) are hematopoietic stem cell malignancies. Known predisposing factors to adult MDS include rare germline mutations, cytotoxic therapy, age-related clonal hematopoiesis, and autoimmune or chronic inflammatory disorders. To date, no published studies characterizing MDS-associated germline susceptibility polymorphisms exist. We performed a genome-wide association study of 2 sample sets (555 MDS cases vs 2964 control subjects; 352 MDS cases vs 2640 control subjects) in non-del(5q) MDS cases of European genomic ancestry. Meta-analysis identified 8 MDS-associated loci at 1q31.1 (PLA2G4A), 3p14.1 (FAM19A4), 5q21.3 (EFNA5), 6p21.33, 10q23.1 (GRID1), 12q24.32, 15q26.1, and 20q13.12 (EYA2) that approached genome-wide significance. Gene expression for 5 loci that mapped within or near genes was significantly upregulated in MDS bone marrow cells compared with those of control subjects (P < .01). Higher PLA2G4A expression and lower EYA2 expression were associated with poorer overall survival (P = .039 and P = .037, respectively). Higher PLA2G4A expression is associated with mutations in NRAS (P < .001), RUNX1 (P = .012), ASXL1 (P = .007), and EZH2 (P = .038), all of which are known to contribute to MDS development. EYA2 expression was an independently favorable risk factor irrespective of age, sex, and Revised International Scoring System score (relative risk, 0.67; P = .048). Notably, these genes have regulatory roles in innate immunity, a critical driver of MDS pathogenesis. EYA2 overexpression induced innate immune activation, whereas EYA2 inhibition restored colony-forming potential in primary MDS cells indicative of hematopoietic restoration and possible clinical relevance. In conclusion, among 8 suggestive MDS-associated loci, 5 map to genes upregulated in MDS with functional roles in innate immunity and potential biological relevance to MDS.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. McGraw KL, Cheng CH, Chen YA, et al. Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis. Blood Adv. 2019. PMID: 31738830. doi:10.1182/bloodadvances.2019000922

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。